Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Cullen

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
British Medical Journal|March 4, 1978
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological typeT A Lister, M H Cullen, M E Beard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histologyT A Lister, M H Cullen, R B Brearley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaE M Bessell, A Burton, A P Haynes, et al.
British Journal of Cancer|December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working PartyA Horwich, R T Oliver, P M Wilkinson, et al.
Cancer|November 15, 1980
Chemotherapy and immunotherapy for acute myelogenous leukemiaT A Lister, J M Whitehouse, R T Oliver, et al.
Oncology Reports|June 26, 2008
A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient settingS A Hussain, D H Palmer, D E Swinson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyS D Fosså, R T Oliver, S P Stenning, et al.
British Journal of Cancer|June 2, 2005
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)D P Dearnaley, S D Fossa, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working PartyG M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer TrialA Horwich, D T Sleijfer, S D Fosså, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
British Medical Journal|March 4, 1978
Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological typeT A Lister, M H Cullen, M E Beard, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1978
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histologyT A Lister, M H Cullen, R B Brearley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A randomised multicentre trial of modified CHOP versus MCOP in patients aged 65 years and over with aggressive non-Hodgkin's lymphomaE M Bessell, A Burton, A P Haynes, et al.
British Journal of Cancer|December 6, 2000
A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working PartyA Horwich, R T Oliver, P M Wilkinson, et al.
Cancer|November 15, 1980
Chemotherapy and immunotherapy for acute myelogenous leukemiaT A Lister, J M Whitehouse, R T Oliver, et al.
Oncology Reports|June 26, 2008
A phase II clinical trial of gemcitabine and split dose cisplatin in advanced non-small cell lung cancer in an outpatient settingS A Hussain, D H Palmer, D E Swinson, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapyS D Fosså, R T Oliver, S P Stenning, et al.
British Journal of Cancer|June 2, 2005
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)D P Dearnaley, S D Fossa, S B Kaye, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working PartyG M Duchesne, S P Stenning, N Aass, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer TrialA Horwich, D T Sleijfer, S D Fosså, et al.
Pageof 9